Have you seen this pill?

This may be the "secret weapon" behind curing one of the world's most horrible disease September 30, 2015 Have you seen this pill? Dear Rude Awakening Reader, Have you seen this pill? Researchers at UCLA and Texas A&M just made a HUGE discovery about this pill... and how it will affect millions of Americans. In fact, if they're correct, this "orange aspirin" may be the "secret weapon" to curing one of the world's most horrible diseases... (Click here to find out which one.) In clinical trials it's rescued patients from complete incontinence and delusional behavior to living quietly at home with their families. This is must see for any American over 55. Click here to discover their unlikely story. Regards, Greg Guenthner Managing editor, The Rude Awakening The Rude Awakening is committed to protecting and respecting your privacy. We do not rent or share your email address. By submitting your email address, you consent to Agora Financial delivering daily email issues and advertisements. To end your Rude Awakening e-mail subscription and associated external offers sent from The Rude Awakening, click here. Please read our Privacy Statement. For any further comments or concerns please email us at rude@agorafinancial.com. If you are you having trouble receiving your Rude Awakening subscription, you can ensure its arrival in your mailbox by whitelisting The Rude Awakening. © 2015 Agora Financial, LLC. 808 Saint Paul Street, Baltimore MD 21202. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in any security they personally recommend to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of a printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.